Sofiva Genomics Co.,Ltd. (TPEX:6615)

Market Cap	708.26M +3.5%
Revenue (ttm)	379.21M -6.7%
Net Income	14.23M
EPS	0.32
Shares Out	21.59M
PE Ratio	102.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,671
Open	32.90
Previous Close	32.95
Day's Range	31.95 - 32.95
52-Week Range	28.90 - 40.00
Beta	0.21
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessm...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2012
• Employees: 104
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6615

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error